Connection
Elaine Morrato to Dyslipidemias
This is a "connection" page, showing publications Elaine Morrato has written about Dyslipidemias.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.462 |
|
|
|
-
Morrato EH, Druss BG, Hartung DM, Valuck RJ, Thomas D, Allen R, Campagna E, Newcomer JW. Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users. Pharmacoepidemiol Drug Saf. 2011 Jan; 20(1):66-75.
Score: 0.320
-
Morrato EH, Druss B, Hartung DM, Valuck RJ, Allen R, Campagna E, Newcomer JW. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs. Arch Gen Psychiatry. 2010 Jan; 67(1):17-24.
Score: 0.075
-
Morrato EH, Newcomer JW, Allen RR, Valuck RJ. Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data. J Clin Psychiatry. 2008 Feb; 69(2):316-22.
Score: 0.066